Lambda Red Recombineering of Bacteriophage in the Lysogenic State. In Methods in Molecular Biology
Tridgett M. et al, (2025), Methods in molecular biology (Clifton, N.J.)
Scarless Recombineering of Phage in Lysogenic State
Ababi M. et al, (2025), Methods in molecular biology (Clifton, N.J.)
Author Correction: The α-globin super-enhancer acts in an orientation-dependent manner.
Kassouf MT. et al, (2025), Nat Commun, 16
Characterization of quinazolinone calcilytic therapy for autosomal dominant hypocalcemia type 1 (ADH1).
Hannan FM. et al, (2025), J Biol Chem
Provision of peri-operative patient blood management strategies in the UK: a national survey of practice.
Warnakulasuriya SR. et al, (2025), Anaesthesia
The Power of Mouse Models in the Diagnostic Odyssey of Patients with Rare Congenital Anomalies
Twigg S., (2025), Mammalian Genome
A rare splice-site variant in TNNT2: the need for ancestral diversity in genomic reference data sets.
Butters A. et al, (2025), Eur Heart J
Early Versus Delayed Invasive Management of Female Patients With Non–ST-Elevation Acute Coronary Syndrome: An Individual Patient Data Meta-Analysis
Mills GB. et al, (2025), Circulation: Cardiovascular Interventions
Fabry Disease: Insights into Pathophysiology and Novel Therapeutic Strategies
Thompson SE. et al, (2025), Biomedicines, 13, 624 - 624
BCL11B-related disease: a single phenotypic entity?
Vedovato-dos-Santos JH. et al, (2025), European Journal of Human Genetics
Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities
Loesch DP. et al, (2025), Nature Communications, 16
Structural and functional insights into α-actinin isoforms and their implications in cardiovascular disease.
Noureddine M. et al, (2025), J Gen Physiol, 157
Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial.
Chia JWK. et al, (2025), Lancet Gastroenterol Hepatol, 10, 198 - 209
Development of a key performance indicator set for perioperative red blood cell transfusion
Shah A. et al, (2025), BJA Open, 13
Prognosis and Risk Stratification in Dilated Cardiomyopathy With LVEF≤35%: Cardiac MRI Insights for Better Outcomes.
Zhou D. et al, (2025), Circ Cardiovasc Imaging, 18